Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 2Phase 3 2Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Prostatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 4Head and Neck Neoplasms 3Wilms Tumor 2Squamous Cell Carcinoma of Head and Neck 2Neurotoxicity Syndromes 2Lung Neoplasms 2Brain Neoplasms 2Untreated Childhood Medulloblastoma 1Tongue Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Intraductal Neoplasms 1Ototoxicity 1Oligodendroglioma 1Obesity 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Liposarcoma 1Leukemia, Myelomonocytic, Chronic 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Gliosarcoma 1

Interventions

Cisplatin 52Radiotherapy 43Cetuximab 30Fluorouracil 27pembrolizumab 19Carboplatin 19Docetaxel 14Paclitaxel 8Radiotherapy, Intensity-Modulated 7Nivolumab 6Methotrexate 6Drug Therapy 6Surgical Procedures, Operative 5Chemotherapy, Adjuvant 5Radiation 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4nimotuzumab 3Taxes 3Chemoradiotherapy 3toripalimab 2lenvatinib 2epacadostat 2durvalumab 2dehydroftorafur 2camrelizumab 2avelumab 2advexin 2Specimen Handling 2Radiotherapy, Conformal 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Squamous Cell Carcinoma of Head and Neck × Radiotherapy, Conformal × Clear all
NCT00820248 2023-08-22

Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

Canadian Cancer Trials Group

Phase 3 Completed
320 enrolled 13 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡